HLB Life Science CO.,LTD.

067630· KOSDAQ· Health Care· Health Care Equipment & Services

₩2,170+5.60%

2026-08-04

Financials

Valuation Metrics

HLB Life Science CO.,LTD.'s Market Cap is ₩2646B. At end of 2025 it was ₩4724B. Ranked #689 of 2,436 in KR market (top 28%), #283 of 1,649 on KOSDAQ (top 17%), #19 of 96 in Health Care Equipment & Services (top 20%) by Market Cap.

Investment Metrics(as of 2026-08-04)

Metric	Value	Rank
Size
Market Cap	264.56B KRW	KR#689/2,436 Sec#19/96
Revenue	33.47B KRW	KR#1,984/2,436 Sec#60/96
Net Income	-50.53B KRW	KR—/2,436 Sec—/96
Total Assets	485.00B KRW	KR#758/2,436 Sec#12/96
Net Assets	293.98B KRW	KR#706/2,436 Sec#12/96
Employees	169	KR#1,216/2,436 Sec#39/96
Value
P/B	0.90x	KR#1,389/2,436 Sec#31/96
P/S	7.90x	KR#2,238/2,436 Sec#79/96
FCF Yield	-18.34%	KR—/2,436 Sec—/96
Profitability
ROE	-17.19%	KR#2,027/2,436 Sec#70/96
ROA	-10.42%	KR#2,089/2,436 Sec#69/96
Op. Margin	-67.34%	KR#2,271/2,436 Sec#79/96
Revenue Growth	-44.68%	KR#2,259/2,436 Sec#86/96
Earnings Growth	-1710.25%	KR#1,715/2,436 Sec#59/96
Financial Health
Debt Ratio	64.98%	KR#218/2,436 Sec#8/96
Total Debt	161.40B KRW	KR#561/2,436 Sec#10/96
FCF	-48.51B KRW	KR#2,087/2,436 Sec#81/96
Cash	14.48B KRW	KR#1,438/2,436 Sec#44/96
Current Ratio	0.55x	KR#2,226/2,436 Sec#91/96
Performance
1Y Return	-52.93%	KR#2,130/2,436 Sec#78/96
1M Return	-30.23%	KR#2,363/2,436 Sec#95/96
From 52W High	-59.29%	KR#1,672/2,436 Sec#58/96
1Y MDD	-70.50%	KR#1,973/2,436 Sec#74/96
Trading
Volume	333,872 shares	KR#366/2,436 Sec#12/96
Foreign Own.	5.19%	KR#779/2,436 Sec#27/96
Per Share
EPS	-414 KRW	KR—/2,436 Sec—/96
BPS	2,410 KRW	KR#1,934/2,436 Sec#61/96

Company Info

CEO 남상우

Employees 169

Founded 1998

HQ 경기도 화성시, KR

Website www.hlb-ls.com

동사는 1998년 설립, 2008년 코스닥 상장 후 2015년 에이치엘비생명과학으로 변경했으며, 2023년 화진메디칼 합병을 완료함. 2025년 티니코 지분 100% 인수로 의료기기 사업 확대함. 메디케어 분야에서는 의료기기 개발·제조와 위탁생산을, 의료기기 분야에서는 주사기 제조·판매를, 바이오개발 분야에서는 표적항암제·바이오인공간을, 에너지 분야에서는 태양광 EPC·폐기물 소각열 사업을 하고 있음. HLB생명과학는 1998년에 설립되었으며 경기도 화성시에 본사를 두고 있습니다.